A detailed history of Callan Family Office, LLC transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Callan Family Office, LLC holds 2,074 shares of IDXX stock, worth $1.43 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,074
Previous 2,486 16.57%
Holding current value
$1.43 Million
Previous $1.33 Billion 0.62%
% of portfolio
0.04%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025

SELL
$514.61 - $682.78 $212,019 - $281,305
-412 Reduced 16.57%
2,074 $1.33 Billion
Q2 2025

Jul 24, 2025

BUY
$361.04 - $536.34 $700,056 - $1.04 Million
1,939 Added 354.48%
2,486 $1.33 Billion
Q1 2025

May 12, 2025

SELL
$406.29 - $469.04 $19,908 - $22,982
-49 Reduced 8.22%
547 $230 Million
Q4 2024

Feb 06, 2025

BUY
$406.92 - $495.42 $242,524 - $295,270
596 New
596 $246 Million

Others Institutions Holding IDXX

About IDEXX LABORATORIES INC


  • Ticker IDXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 83,253,696
  • Market Cap $57.4B
  • Description
  • IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...
More about IDXX
Track This Portfolio

Track Callan Family Office, LLC Portfolio

Follow Callan Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Callan Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Callan Family Office, LLC with notifications on news.